Archives: Agenda

• Optimize clinical trade compliance by ensuring precise material classification and valuation
• Collaborating with brokers and logistics partners to ensure compliant, efficient
• importation
• Determining duty rates and entry rates for different types of clinical trial materials and products
• Applying for duty exemptions: are you eligible?

• How to plan and allocate resources effectively across the full study lifecycle (from manufacturing to release and distribution)
• How to prepare for audits and inspections proactively incorporating audit readiness into daily workflows to avoid last minute firefighting
• The value of leveraging external partners and CDMOs effectively to improve quality oversight with limited internal teams

AI is powerful, but the drug and the patient come first. This boardroom explores how teams can leverage AI safely, integrate it into workflows, and maintain human control with strong processes.

Outcome: Each table will collaborate to create practical strategies, and governance approaches that balance AI capabilities with human oversight, ensuring AI enhances decisions rather than replacing critical thinking.

A variety of alcoholic and soft drinks will be served

AI is powerful, but the drug and the patient come first. This boardroom explores how teams can leverage AI safely, integrate it into workflows, and maintain human control with strong processes.

Outcome: Each table will collaborate to create practical strategies, and governance approaches that balance AI capabilities with human oversight, ensuring AI enhances decisions rather than replacing critical thinking.

A variety of alcoholic and soft drinks will be served